Posted: 12h ago
The role
NSS delivers four national population-based screening programmes – for cervical, breast and bowel screening and for detecting sight‑threatening retinopathy in people with diabetes.
Our programmes focus on looking for early signs of disease in healthy people, so that we can:
detect health issues early
help prevent disease
ensure that anyone who does develop the disease being screened for has the best chance of early, more effective treatment
reduce people’s risk of developing a disease or its complications
support people in making informed decisions about their health
Choose Screening: Together we can make a difference. The National Screening Service 5‑year Strategic Plan outlines our strategic priorities and goals for the years 2023-2027.
Our mission: We deliver population screening programmes that help prevent, reduce the risk of, and assist the recognition of disease in Ireland.
Our vision: To work together to save lives and improve people’s health through population screening. The role of the National Screening Service also includes policy, development and advice.
The Opportunity: To participate in the provision of a high‑quality Cellular Pathology service in DAP and to perform duties in a manner that provides a high‑quality service to users in accordance with relevant ISO standards. This post will support the pathology service requirements for the reporting of BreastCheck breast cancer specimens as a priority. Resulting from amalgamation of the Pathology Unit and the BreastCheck West screening service with the Department of Pathology, GUH, there will be a focus on general pathology specimens also.
2026 graduates are eligible to apply for this campaign.
Candidates must have, at the latest date of application:
Statutory Registration, Professional Qualifications, Experience.
Be registered on the Medical Scientists Register maintained by the Medical Scientists Registration Board at CORU.
Applicants who satisfy the conditions set out in Section 91 of the Health and Social Care Professionals Act 2005, must submit proof of application for registration with the Medical Scientists Registration Board at CORU. The acceptable proof is correspondence from the Board confirming their application for registration as a Section 91 applicant was received by the 30th March 2021.
Qualifications:
Possess one of the following NFQ Level 9 postgraduate qualifications or equivalent qualification at minimum Level 9 validated by the Academy of Clinical Science and Laboratory Medicine: MSc Clinical Laboratory Science (DIT), MSc Clinical Chemistry (TCD), MSc Biomedical Science (UU), MSc Biomedical Science (University College Cork), MSc Molecular Pathology (DIT), (DIT)/University of Dublin, Trinity College (TCD).
Or an equivalent qualification at minimum Level 9 validated by ACSLM.
Or possess Fellowship of the Academy of Clinical Science and Laboratory Medicine awarded before July 2018.
Or have attained the Fellowship examination of the Institute of Biomedical Science (Awarded prior to 1999).
Possess four years full‑time clinical experience (or an aggregate of four years’ full‑time clinical experience) as a medical scientist in a clinical diagnostic laboratory since qualifying as a medical scientist.
Demonstrate evidence of Continuous Professional Development.
Requirements for registration and ongoing status:
Annual registration on Medical Scientists Register maintained by the Medical Scientists Registration Board at CORU.
Confirm annual registration with CORU to the HSE by way of the annual Patient Safety Assurance Certificate (PSAC).
Health: A candidate must be fully competent and capable of undertaking the duties attached to the office and be in a state of health that would indicate a reasonable prospect of ability to render regular and efficient service.
Character: Each candidate must be of good character.
Join our team and we'll provide you with the support you need to deliver and succeed. This is an unmissable opportunity to join a diverse and supportive workplace where staff feel valued.
#J-18808-Ljbffr
